SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001679082-17-000026
Filing Date
2017-11-13
Accepted
2017-11-13 16:41:09
Documents
44
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q myovant10q93017.htm 10-Q 827318
2 EXHIBIT 10.1 myovantex10193017.htm EX-10.1 75138
3 EXHIBIT 10.2 myovantex10293017.htm EX-10.2 75384
4 EXHIBIT 31.1 myovantex31193017.htm EX-31.1 9450
5 EXHIBIT 31.2 myovantex31293017.htm EX-31.2 9568
6 EXHIBIT 32.1 myovantex32193017.htm EX-32.1 6258
7 EXHIBIT 32.2 myovantex32293017.htm EX-32.2 5949
  Complete submission text file 0001679082-17-000026.txt   2654459

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT axon-20170930.xml EX-101.INS 229790
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axon-20170930.xsd EX-101.SCH 22865
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axon-20170930_cal.xml EX-101.CAL 41918
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axon-20170930_def.xml EX-101.DEF 94466
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axon-20170930_lab.xml EX-101.LAB 324070
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axon-20170930_pre.xml EX-101.PRE 174283
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS (441) 824-8101
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37929 | Film No.: 171196559
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences